Cargando…
Therapeutic effects of conditioned medium from bone marrow-derived mesenchymal stem cells on epithelial-mesenchymal transition in A549 cells
Pulmonary fibrosis (PF) is a chronic lung disease. The transforming growth factor-β1 (TGF-β1)/Smad3 signaling pathway plays an important role in the pathogenesis of pulmonary fibrosis. Bone marrow-derived mesenchymal stem cells (BMSCs) have been shown to be a modulator of the molecular aspects of th...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5752235/ https://www.ncbi.nlm.nih.gov/pubmed/29207055 http://dx.doi.org/10.3892/ijmm.2017.3284 |
_version_ | 1783290093674430464 |
---|---|
author | Wang, Xin Gao, Jun-Ling Zhao, Man-Man Zhu, Hui-Xing Tian, Yan-Xia Li, Ran Jiang, Xiao-Hua Yu, Lei Tian, Jing-Rui Cui, Jian-Zhong |
author_facet | Wang, Xin Gao, Jun-Ling Zhao, Man-Man Zhu, Hui-Xing Tian, Yan-Xia Li, Ran Jiang, Xiao-Hua Yu, Lei Tian, Jing-Rui Cui, Jian-Zhong |
author_sort | Wang, Xin |
collection | PubMed |
description | Pulmonary fibrosis (PF) is a chronic lung disease. The transforming growth factor-β1 (TGF-β1)/Smad3 signaling pathway plays an important role in the pathogenesis of pulmonary fibrosis. Bone marrow-derived mesenchymal stem cells (BMSCs) have been shown to be a modulator of the molecular aspects of the fibrosis pathway. However, it is still unknown as to whether the conditioned medium from BMSCs (BMSCs-CM) inhibits the epithelial-mesenchymal transition (EMT) process. This study confirmed the hypothesis that BMSCs-CM exerts an anti-fibrotic effect on human type II alveolar epithelial cells (A549) by suppressing the phosphorylation of Smad3. We used the A549 cells in vitro to detect morphological evidence of EMT by phase-contrast microscopy. These cells were randomly divided into 4 groups as follows: the control group, the TGF-β1 group, the SIS3 (specific inhibitor of Smad3) group and the BMSCs-CM group. The immunofluorescence method was used to determined the location of E-cadherin (E-calcium mucins; E-cad), α-smooth muscle actin (α-SMA) and p-Smad3. The expression levels of E-cad, CK8, α-SMA, vimentin, p-Smad3, Snail1, collagen I (COLI) and collagen III (COLIII) were detected by western blot analysis. Following exposure to TGF-β1, the A549 cells displayed a spindle-shaped fibroblast-like morphology. In accordance with these morphological changes, the expression levels of E-cad and CK8 were downregulated, while the expression levels of α-SMA and vimentin were upregulated. Along with this process, the expression levels of p-Smad3, Snail1, COLI and COLIII were increased. However, the cells in the BMSCs-CM group and SIS3 group exhibited a decrease in the levels of α-SMA and vimentin (which had been upregulated by TGF-β1), and an increase in the levels of E-cad and CK8 expression (which had been downregulated by TGF-β1). On the whole, these results indicated that BMSCs-CM suppressed the EMT which might be associated with TGF-β1/Smad3. This study provides the theoretical basis for the research of the mechanisms responsible for pulmonary disease. |
format | Online Article Text |
id | pubmed-5752235 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-57522352018-01-11 Therapeutic effects of conditioned medium from bone marrow-derived mesenchymal stem cells on epithelial-mesenchymal transition in A549 cells Wang, Xin Gao, Jun-Ling Zhao, Man-Man Zhu, Hui-Xing Tian, Yan-Xia Li, Ran Jiang, Xiao-Hua Yu, Lei Tian, Jing-Rui Cui, Jian-Zhong Int J Mol Med Articles Pulmonary fibrosis (PF) is a chronic lung disease. The transforming growth factor-β1 (TGF-β1)/Smad3 signaling pathway plays an important role in the pathogenesis of pulmonary fibrosis. Bone marrow-derived mesenchymal stem cells (BMSCs) have been shown to be a modulator of the molecular aspects of the fibrosis pathway. However, it is still unknown as to whether the conditioned medium from BMSCs (BMSCs-CM) inhibits the epithelial-mesenchymal transition (EMT) process. This study confirmed the hypothesis that BMSCs-CM exerts an anti-fibrotic effect on human type II alveolar epithelial cells (A549) by suppressing the phosphorylation of Smad3. We used the A549 cells in vitro to detect morphological evidence of EMT by phase-contrast microscopy. These cells were randomly divided into 4 groups as follows: the control group, the TGF-β1 group, the SIS3 (specific inhibitor of Smad3) group and the BMSCs-CM group. The immunofluorescence method was used to determined the location of E-cadherin (E-calcium mucins; E-cad), α-smooth muscle actin (α-SMA) and p-Smad3. The expression levels of E-cad, CK8, α-SMA, vimentin, p-Smad3, Snail1, collagen I (COLI) and collagen III (COLIII) were detected by western blot analysis. Following exposure to TGF-β1, the A549 cells displayed a spindle-shaped fibroblast-like morphology. In accordance with these morphological changes, the expression levels of E-cad and CK8 were downregulated, while the expression levels of α-SMA and vimentin were upregulated. Along with this process, the expression levels of p-Smad3, Snail1, COLI and COLIII were increased. However, the cells in the BMSCs-CM group and SIS3 group exhibited a decrease in the levels of α-SMA and vimentin (which had been upregulated by TGF-β1), and an increase in the levels of E-cad and CK8 expression (which had been downregulated by TGF-β1). On the whole, these results indicated that BMSCs-CM suppressed the EMT which might be associated with TGF-β1/Smad3. This study provides the theoretical basis for the research of the mechanisms responsible for pulmonary disease. D.A. Spandidos 2018-02 2017-11-24 /pmc/articles/PMC5752235/ /pubmed/29207055 http://dx.doi.org/10.3892/ijmm.2017.3284 Text en Copyright: © Wang et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Articles Wang, Xin Gao, Jun-Ling Zhao, Man-Man Zhu, Hui-Xing Tian, Yan-Xia Li, Ran Jiang, Xiao-Hua Yu, Lei Tian, Jing-Rui Cui, Jian-Zhong Therapeutic effects of conditioned medium from bone marrow-derived mesenchymal stem cells on epithelial-mesenchymal transition in A549 cells |
title | Therapeutic effects of conditioned medium from bone marrow-derived mesenchymal stem cells on epithelial-mesenchymal transition in A549 cells |
title_full | Therapeutic effects of conditioned medium from bone marrow-derived mesenchymal stem cells on epithelial-mesenchymal transition in A549 cells |
title_fullStr | Therapeutic effects of conditioned medium from bone marrow-derived mesenchymal stem cells on epithelial-mesenchymal transition in A549 cells |
title_full_unstemmed | Therapeutic effects of conditioned medium from bone marrow-derived mesenchymal stem cells on epithelial-mesenchymal transition in A549 cells |
title_short | Therapeutic effects of conditioned medium from bone marrow-derived mesenchymal stem cells on epithelial-mesenchymal transition in A549 cells |
title_sort | therapeutic effects of conditioned medium from bone marrow-derived mesenchymal stem cells on epithelial-mesenchymal transition in a549 cells |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5752235/ https://www.ncbi.nlm.nih.gov/pubmed/29207055 http://dx.doi.org/10.3892/ijmm.2017.3284 |
work_keys_str_mv | AT wangxin therapeuticeffectsofconditionedmediumfrombonemarrowderivedmesenchymalstemcellsonepithelialmesenchymaltransitionina549cells AT gaojunling therapeuticeffectsofconditionedmediumfrombonemarrowderivedmesenchymalstemcellsonepithelialmesenchymaltransitionina549cells AT zhaomanman therapeuticeffectsofconditionedmediumfrombonemarrowderivedmesenchymalstemcellsonepithelialmesenchymaltransitionina549cells AT zhuhuixing therapeuticeffectsofconditionedmediumfrombonemarrowderivedmesenchymalstemcellsonepithelialmesenchymaltransitionina549cells AT tianyanxia therapeuticeffectsofconditionedmediumfrombonemarrowderivedmesenchymalstemcellsonepithelialmesenchymaltransitionina549cells AT liran therapeuticeffectsofconditionedmediumfrombonemarrowderivedmesenchymalstemcellsonepithelialmesenchymaltransitionina549cells AT jiangxiaohua therapeuticeffectsofconditionedmediumfrombonemarrowderivedmesenchymalstemcellsonepithelialmesenchymaltransitionina549cells AT yulei therapeuticeffectsofconditionedmediumfrombonemarrowderivedmesenchymalstemcellsonepithelialmesenchymaltransitionina549cells AT tianjingrui therapeuticeffectsofconditionedmediumfrombonemarrowderivedmesenchymalstemcellsonepithelialmesenchymaltransitionina549cells AT cuijianzhong therapeuticeffectsofconditionedmediumfrombonemarrowderivedmesenchymalstemcellsonepithelialmesenchymaltransitionina549cells |